{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:07:41Z","timestamp":1754093261154,"version":"3.41.2"},"reference-count":13,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background: Venous thromboembolism (VTE) is a multifactorial disease. There are two main clinical entities that are associated with morbidity and mortality, deep vein thrombosis and pulmonary embolism. Our study aimed to compare the three risk assessment models (RAMs), Khorana, Caprini and Padua in terms of predicting VTE in gynaecologic oncology patients.\n\nMethods: Patients were retrospectively scored according to Caprini, Padua and Khorana scoring models to assess the risk for VTE. Accuracy analysis of risk assessment models was performed using sensitivity, specificity, positive and negative predictive values as well as the area under the curve of each model per patient.\n\nResults: The Caprini score has good sensitivity (80.0), a poor specificity (24.3), low positive predictive value (7.2) and good negative predictive value (94.3) (95% CI). The Khorana score has a poor sensitivity (30.0), a fair specificity (62.5), low positive predictive value (5.6) and good negative predictive value (92.4) (95% CI). The Padua score has an average sensitivity (60.0), a poor specificity (42.6), low positive predictive value (7.1) and good negative predictive value (93.5) (95% CI). The Caprini score had the overall best performance.\n\nConclusion: Caprini score performed better and proved to be the best score. It has the potential to reduce mortality associated with VTE in gynaecological cancer patients. However, the Caprini score needs to be tested in the same population in a prospective study in a multicentre.\n\nContribution: The results of this study prove to us that Caprini score is the best to be used in a South African setting.<\/jats:p>","DOI":"10.4102\/jcmsa.v3i1.164","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:55:08Z","timestamp":1754031308000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The predictive value of risk assessment models for venous thromboembolism on gynaecological cancer patients"],"prefix":"10.4102","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2317-3777","authenticated-orcid":false,"given":"Phuti","family":"Ratshabedi","sequence":"first","affiliation":[{"name":"University of the Witwatersrand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4954-2225","authenticated-orcid":false,"given":"Admire","family":"Chikandiwa","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5950-791X","authenticated-orcid":false,"given":"Langanani","family":"Mbodi","sequence":"additional","affiliation":[{"name":"University of the Witwatersrand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2580","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Riondino S, Ferroni P, Zanzotto FM, Roselli M, Guadagni F. Predicting VTE in cancer patients: Candidate biomarkers and risk assessment models. Cancers (Basel). 2019;11(1):95. https:\/\/doi.org\/10.3390\/cancers11010095","DOI":"10.3390\/cancers11010095"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Mulder FI, Candeloro M, Kamphuisen PW, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis. Haematologica. 2019;104(6):1277\u20131287. https:\/\/doi.org\/10.3324\/haematol.2018.209114","DOI":"10.3324\/haematol.2018.209114"},{"key":"ref2","unstructured":"Kawaguchi H, Kanemura M, Nakamura M, et al. High incidence of VTE in gynaecological cancer patients before surgery. Bull Osaka Med Coll. 2013;59(1):9\u201316."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Nawapas P, Putsarat I, Suvanna A. Risk factor of deep vein thrombosis development among gynecologic cancer patients. Asian Pac J Cancer Care. 2018;3(1):5\u201311. https:\/\/doi.org\/10.31557\/apjcc.2018.3.1.5","DOI":"10.31557\/apjcc.2018.3.1.5"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Liu X, Liu C, Chen X, Wu W, Lu G. Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: A retrospective study. Interact CardioVasc Thorac Surg. 2016;23(4):538\u2013543. https:\/\/doi.org\/10.1093\/icvts\/ivw158","DOI":"10.1093\/icvts\/ivw158"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Zhou H, Hu Y, Li X, et al.. Assessment of the risk of venous thromboembolism in medical inpatients using the Padua prediction score and Caprini risk assessment model. J Atheroscler Thromb. 2018;25(11):1091\u20131104. https:\/\/doi.org\/10.5551\/jat.43653","DOI":"10.5551\/jat.43653"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Moodley P, Martisan NA, Yoyimbana W, et al. Venous thromboembolic disease in adults admitted to hospital in a setting with a high burden of HIV and TB [homepage on the Internet]. 2022 [cited 2024 Nov]. Available from: https:\/\/hdl.handle.net\/10520\/ejc-m_ajtccm_v27_n3_a6","DOI":"10.7196\/AJTCCM.2021.v27i3.155"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Cheng YJ, Liu ZH, Yao FJ, et al. Current and former smoking and risk for venous thromboembolism: A systematic review and meta-analysis. PLoS Med. 2013;10(9):e1001515. https:\/\/doi.org\/10.1371%2Fjournal.pmed.1001515","DOI":"10.1371\/journal.pmed.1001515"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Paulsen B, Gran VO, Severinsen MT, et al. Association of smoking and cancer with the risk of venous thromboembolism: The Scandinavian Thrombosis and Cancer cohort. Sci Rep. 2021;11:18752. https:\/\/doi.org\/10.1038\/s41598-021-98062-0","DOI":"10.1038\/s41598-021-98062-0"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Matsuo K, Ross MS, Im DD, et al. Significance of venous thromboembolism in women with uterine carcinosarcoma. Gyneacol Oncol. 2018;148(2):267\u2013274. https:\/\/doi.org\/10.1016\/j.ygyno.2017.11.036","DOI":"10.1016\/j.ygyno.2017.11.036"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Snyman LC, Potgieter J. Venous thromboembolism: Risk profile and management of prophylaxis in gynaecological surgery patients. S Afr J OG. 2014;20(3):76\u201379. https:\/\/doi.org\/10.7196\/sajog.490","DOI":"10.7196\/sajog.490"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Wang Y, Attar BM, Fuentes HE, Yu J, Zhang H, Tafur AJ. Performance of Khorana risk score for prediction of venous thromboembolism in patients with hepatocellular carcinoma. Clin Appl Thrombo Hemostasis. 2018;24(3):471\u2013476. https:\/\/doi.org\/10.1177\/1076029617699088","DOI":"10.1177\/1076029617699088"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Wehmeyer A, Coetzee R, Mccartney J. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa. S Afr Med J. 2022;112(2):117\u2013123. https:\/\/doi.org\/10.7196\/SAMJ.2022.v112i2.16040","DOI":"10.7196\/SAMJ.2022.v112i2.16040"}],"container-title":["Journal of the Colleges of Medicine of South Africa"],"original-title":[],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:55:14Z","timestamp":1754031314000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcmsa.org.za\/index.php\/jcmsa\/article\/view\/164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/jcmsa.v3i1.164","relation":{},"ISSN":["2960-110X"],"issn-type":[{"value":"2960-110X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"article-number":"a164"}}